Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Kestra Medical Technologies, Ltd.

NASDAQ: KMTS · Industrial Applications and Services · 7 alerts · CIK 1877184

Share price
$27.97Close, Nov 16
Market cap
$1.67B
Shares outstanding
59.56MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Kestra Medical Technologies, Ltd. filings on SEC EDGAR ↗

5:41 PM ET Form 4
Insider Selling

Kestra Medical Technologies Chief Business Officer Timothy P. Moran Sells $94.4K of Stock

Timothy P. Moran, Chief Business Officer, sold 3,192 shares of Kestra Medical Technologies, Ltd. at $29.56 a share, worth $94.4K in total on Nov 3, 2026. Shares held after the trade: 63,153 (-4.8%).

Value
$94.4K
Shares
3,192
Price
$29.56
Role
Chief Business Officer
Holding change
-4.8%
Trade date
Nov 3, 2026
6:47 PM ET Form 4
Insider Selling

Kestra Medical Technologies CFO Vaseem Mahboob Sells $2.41M of Stock

Vaseem Mahboob, CFO, sold 79,500 shares of Kestra Medical Technologies, Ltd. at $30.04 to $30.60 a share (average $30.30) in 3 transactions, worth $2.41M in total between Oct 27, 2026 and Oct 29, 2026. Shares held after the trade: 60,609 (-7.3%).

Value
$2.41M
Shares
79,500
Average price
$30.30
Role
CFO
Holding change
-7.3%
Trade date
Oct 27, 2026 to Oct 29, 2026
6:44 PM ET Form 4
Insider Selling

Kestra Medical Technologies Insider Traci S. Umberger Sells $901K of Stock

Traci S. Umberger sold 30,000 shares of Kestra Medical Technologies, Ltd. at $30.03 a share, worth $901K in total on Oct 27, 2026. Shares held after the trade: 195,825 (-13.3%).

Value
$901K
Shares
30,000
Price
$30.03
Holding change
-13.3%
Trade date
Oct 27, 2026
4:27 PM ET Form 4
Insider Selling

Kestra Medical Technologies Insider Traci S. Umberger Sells $2.72M of Stock

Traci S. Umberger sold 100,000 shares of Kestra Medical Technologies, Ltd. at $27.15 to $28.09 a share (average $27.18) in 2 transactions, worth $2.72M in total on Oct 21, 2026. Shares held after the trade: 195,825 (-1.8%).

Value
$2.72M
Shares
100,000
Average price
$27.18
Holding change
-1.8%
Trade date
Oct 21, 2026
4:24 PM ET Form 4
Insider Selling

Kestra Medical Technologies Insider Brian Daniel Webster Sells $443K of Stock

Brian Daniel Webster sold 15,000 shares of Kestra Medical Technologies, Ltd. at $29.52 to $29.89 a share (average $29.56) in 2 transactions, worth $443K in total on Oct 20, 2026. Shares held after the trade: 445,215 (-0.4%).

Value
$443K
Shares
15,000
Average price
$29.56
Holding change
-0.4%
Trade date
Oct 20, 2026
6:00 PM ET Form 4
Insider Selling

Kestra Medical Technologies Director Raymond W. Cohen Sells $97.5K of Stock

Raymond W. Cohen, Director, sold 3,330 shares of Kestra Medical Technologies, Ltd. at $29.28 a share, worth $97.5K in total on Sep 30, 2026. Shares held after the trade: 54,790 (-5.7%).

Value
$97.5K
Shares
3,330
Price
$29.28
Role
Director
Holding change
-5.7%
Trade date
Sep 30, 2026
4:06 PM ET 8-K
Financial Results

Kestra Medical Technologies Financial Results

Kestra Medical Technologies reported first quarter fiscal 2027 revenue of $31.0 million, a 60% increase year-over-year, driven by wearable cardioverter defibrillator (WCD) market expansion and competitive gains. The company reported a GAAP net loss of $44.1 million and increased its full-year fiscal 2027 revenue guidance to $141 million.

Term
Q1 2027
Earnings call
Sep 14, 2026, 4:30 PM ET

“Kestra delivered another strong quarter of financial performance, generating revenue growth of 60% while expanding gross margin to over 56%. We remain confident that our focus on innovation and commercial expansion positions Kestra to generate durable, top-tier growth for years to come. Our team is executing on its commitments to prescribers and their patients and we believe this will continue to drive market expansion and advance Kestra on its path to market leadership.”

Brian Webster, President and CEO

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.